Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms
Background: The Philippine cobra (Naja philippinensis) and Samar cobra (Naja samarensis) are two WHO Category 1 medically important venomous snakes in the Philippines. Philippine cobra antivenom (PCAV) is the only antivenom available in the country, but its neutralization capacity against the venoms...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
Oxford University Press
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/26551/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.26551 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.265512022-03-17T01:35:34Z http://eprints.um.edu.my/26551/ Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms Tan, Choo Hock Palasuberniam, Praneetha Blanco, Francis Bonn Tan, Kae Yi R Medicine (General) Background: The Philippine cobra (Naja philippinensis) and Samar cobra (Naja samarensis) are two WHO Category 1 medically important venomous snakes in the Philippines. Philippine cobra antivenom (PCAV) is the only antivenom available in the country, but its neutralization capacity against the venoms of N. philippinensis and hetero-specific N. samarensis has not been reported. This knowledge gap greatly hinders the optimization of antivenom use in the region. Methods: This study examined the immunological binding and neutralization capacity of PCAV against the two cobra venoms using WHO-recommended protocols. Results: In mice, both venoms were highly neurotoxic and lethal with a median lethal dose of 0.18 and 0.20 mu g/g, respectively. PCAV exhibited strong and comparable immunoreactivity toward the venoms, indicating conserved venom antigenicity between the two allopatric species. In in vivo assay, PCAV was only moderately effective in neutralizing the toxicity of both venoms. Its potency was even lower against the hetero-specific N. samarensis venom by approximately two-fold compared with its potency against N. philippinensis venom. Conclusion: The results indicated that PCAV could be used to treat N. samarensis envenomation but at a higher dose, which might increase the risk of hypersensitivity and worsen the shortage of antivenom supply in the field. Antivenom manufacturing should be improved by developing a low-dose, high-efficacy product against cobra envenomation. Oxford University Press 2021-01 Article PeerReviewed Tan, Choo Hock and Palasuberniam, Praneetha and Blanco, Francis Bonn and Tan, Kae Yi (2021) Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms. Transactions of the Royal Society of Tropical Medicine and Hygiene, 115 (1). pp. 78-84. ISSN 0035-9203, DOI https://doi.org/10.1093/trstmh/traa087 <https://doi.org/10.1093/trstmh/traa087>. 10.1093/trstmh/traa087 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
R Medicine (General) |
spellingShingle |
R Medicine (General) Tan, Choo Hock Palasuberniam, Praneetha Blanco, Francis Bonn Tan, Kae Yi Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms |
description |
Background: The Philippine cobra (Naja philippinensis) and Samar cobra (Naja samarensis) are two WHO Category 1 medically important venomous snakes in the Philippines. Philippine cobra antivenom (PCAV) is the only antivenom available in the country, but its neutralization capacity against the venoms of N. philippinensis and hetero-specific N. samarensis has not been reported. This knowledge gap greatly hinders the optimization of antivenom use in the region. Methods: This study examined the immunological binding and neutralization capacity of PCAV against the two cobra venoms using WHO-recommended protocols. Results: In mice, both venoms were highly neurotoxic and lethal with a median lethal dose of 0.18 and 0.20 mu g/g, respectively. PCAV exhibited strong and comparable immunoreactivity toward the venoms, indicating conserved venom antigenicity between the two allopatric species. In in vivo assay, PCAV was only moderately effective in neutralizing the toxicity of both venoms. Its potency was even lower against the hetero-specific N. samarensis venom by approximately two-fold compared with its potency against N. philippinensis venom. Conclusion: The results indicated that PCAV could be used to treat N. samarensis envenomation but at a higher dose, which might increase the risk of hypersensitivity and worsen the shortage of antivenom supply in the field. Antivenom manufacturing should be improved by developing a low-dose, high-efficacy product against cobra envenomation. |
format |
Article |
author |
Tan, Choo Hock Palasuberniam, Praneetha Blanco, Francis Bonn Tan, Kae Yi |
author_facet |
Tan, Choo Hock Palasuberniam, Praneetha Blanco, Francis Bonn Tan, Kae Yi |
author_sort |
Tan, Choo Hock |
title |
Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms |
title_short |
Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms |
title_full |
Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms |
title_fullStr |
Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms |
title_full_unstemmed |
Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms |
title_sort |
immunoreactivity and neutralization capacity of philippine cobra antivenom against naja philippinensis and naja samarensis venoms |
publisher |
Oxford University Press |
publishDate |
2021 |
url |
http://eprints.um.edu.my/26551/ |
_version_ |
1735409427250413568 |
score |
13.211869 |